According to clinical trial data submitted by Arena to the FDA, nearly half of dieters without Type 2 diabetes who used the medication lost at least 5% of their starting weight — or an average of 12 lbs. — over a year, compared with 23% of those taking a placebo. For best results, dieters are advised to use the medication together with a healthy diet and exercise program. The approved labeling for Belviq also recommends that people discontinue the drug if they fail to lose 5% of their body weight after 12 weeks; longer treatment is unlikely to lead to meaningful weight loss.
Lorcaserin works by helping you feel full with smaller meals. Lorcaserin is used together with diet and exercise to treat obesity. Lorcaserin is sometimes used to treat obesity that may be related to diabetes, high cholesterol, or high blood pressure.
The FDA approval of Belviq is an important development for patients who struggle with obesity or are overweight with comorbidities and need help with chronic weight management beyond diet and exercise.
To maintain weight loss long-term, you’ll have to make permanent changes to your diet and exercise habits. Like all weight loss medications, lorcaserin powder is only recommended under the supervision of your obesity medicine doctor.